Roche

A multinational biotechnology healthcare company, Roche, has lamented the low inclusion of Africa in global pharma studies, revealing that only 2.4 per cent of patients from the continent are enrolled in annual global clinical trials.…

Roche is looking for another location to carry out trials of its pill to fight COVID-19. The Swiss drugmaker said on Wednesday,  plummeting case numbers in Britain made it difficult to find enough patients for its study. Roche and…

Regeneron's COVID-19 antibody cocktail has helped reduce the risk of symptomatic infections by 81% among people in households where another member had become ill. Read Also:EU regulator advises use of Regeneron anti body cocktail for…